MedTrace Logo

The Role of Exercise Training in the Treatment of Resistant Hypertension

NCT03090529 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-12-17

No results posted yet for this study

Summary

The main purpose of this study is to assess whether exercise training reduces ambulatory blood pressure in patients with resistant hypertension. To accomplish these goals 60 patients with resistant hypertension will be recruited and randomized into exercise training or control groups and followed up for 6 months. The patients in the exercise group will participate in a 3-month outpatient program. The control group will receive usual medical care. At baseline, after the intervention and 3 months after the end of the intervention both groups will undergo several evaluations, including casual and ambulatory blood pressure, body composition, cardiorespiratory fitness, quality of life, arterial stiffness, autonomic function, and endothelial and inflammatory biomarkers.

Conditions

  • Resistant Hypertension

Interventions

OTHER

Exercise Group

The 12-week exercise-training program will include three sessions of aerobic exercise per week

Sponsors & Collaborators

  • University Institute of Maia

    collaborator OTHER

  • Cardiology Department, Hospital Infante D. Pedro, Centro Hospitalar do Baixo Vouga

    collaborator UNKNOWN

  • Hypertension and Cardiovascular Unit, Hospital Pedro Hispano, ULS Matosinhos

    collaborator UNKNOWN

  • Cintesis & Departamento de Medicina da Faculdade de Medicina do Porto

    collaborator UNKNOWN

  • Aveiro University

    lead OTHER

Principal Investigators

  • José Mesquita Bastos, MD, PhD · Hospital Infante D. Pedro, Centro Hospitalar Do Baixo Vouga

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2019-12-30
Completion
2020-03-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03090529 on ClinicalTrials.gov